Chapter 33: Problem 11
A modifier gene a. must cause disease. b. alters the expression of a disease. c. must be in linkage disequilibrium with the disease allele. d. all of the above. e. none of the above.
Chapter 33: Problem 11
A modifier gene a. must cause disease. b. alters the expression of a disease. c. must be in linkage disequilibrium with the disease allele. d. all of the above. e. none of the above.
All the tools & learning materials you need for study success - in one app.
Get started for freeLinkage analysis a. is limited by its exclusive use of restriction fragment length polymorphisms b. utilizes co-inheritance of a region of the genome with the disease locus to which it is "linked" c. has the advantage of always identifying causative mutations d. all of the above e. none of the above
The majority of the mutations known to cause neurodegenerative diseases in humans have been discovered for a. common complex diseases because they affect the most people b. diseases with a Mendelian inheritance pattern c. multi-system atrophy d. non-genetic diseases e. diseases with no familial component
Characteristic of FTDP-17 is a. a phenotype that may be mistaken for \(\mathrm{AD}\) b. linkage to chromosome 17 c. abnormal Tau accumulation d. all of the above e. none of the above
Allelic genetic association analyses may find positive associations because the a. allele causes the disease b. allele is in strong linkage disequilibrium with the disease allele c. result is a false positive d. all of the above e. none of the above
Heterogeneity within a disease may manifest as a. allelic heterogeneity, in which many variants of a single gene can cause the same disease b. locus heterogeneity, in which variants in many different genes may cause the same disease c. some of the difficulties underlying genetic studies of neurodegenerative diseases d. all of the above e. none of the above
What do you think about this solution?
We value your feedback to improve our textbook solutions.